Benzinga | Sep 1, 2020 07:39AM EDT

Morgan Stanley Maintains Overweight on Catalent, Raises Price Target to $98

Morgan Stanley maintains Catalent (NYSE:CTLT) with a Overweight and raises the price target from $95 to $98.